1. Home
  2. CYBN vs CBNA Comparison

CYBN vs CBNA Comparison

Compare CYBN & CBNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • CBNA
  • Stock Information
  • Founded
  • CYBN 2019
  • CBNA 2006
  • Country
  • CYBN Canada
  • CBNA United States
  • Employees
  • CYBN N/A
  • CBNA N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • CBNA
  • Sector
  • CYBN Health Care
  • CBNA
  • Exchange
  • CYBN Nasdaq
  • CBNA NYSE
  • Market Cap
  • CYBN 178.7M
  • CBNA 159.8M
  • IPO Year
  • CYBN N/A
  • CBNA 2024
  • Fundamental
  • Price
  • CYBN $7.54
  • CBNA $26.10
  • Analyst Decision
  • CYBN Strong Buy
  • CBNA Buy
  • Analyst Count
  • CYBN 4
  • CBNA 3
  • Target Price
  • CYBN $85.00
  • CBNA $29.67
  • AVG Volume (30 Days)
  • CYBN 412.3K
  • CBNA 9.8K
  • Earning Date
  • CYBN 08-12-2025
  • CBNA 07-28-2025
  • Dividend Yield
  • CYBN N/A
  • CBNA N/A
  • EPS Growth
  • CYBN N/A
  • CBNA 2.39
  • EPS
  • CYBN N/A
  • CBNA 3.56
  • Revenue
  • CYBN N/A
  • CBNA $56,721,000.00
  • Revenue This Year
  • CYBN N/A
  • CBNA N/A
  • Revenue Next Year
  • CYBN N/A
  • CBNA $17.50
  • P/E Ratio
  • CYBN N/A
  • CBNA $7.35
  • Revenue Growth
  • CYBN N/A
  • CBNA 36.60
  • 52 Week Low
  • CYBN $4.81
  • CBNA $20.01
  • 52 Week High
  • CYBN $13.88
  • CBNA $27.97
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 46.24
  • CBNA N/A
  • Support Level
  • CYBN $7.26
  • CBNA N/A
  • Resistance Level
  • CYBN $7.81
  • CBNA N/A
  • Average True Range (ATR)
  • CYBN 0.45
  • CBNA 0.00
  • MACD
  • CYBN -0.04
  • CBNA 0.00
  • Stochastic Oscillator
  • CYBN 17.72
  • CBNA 0.00

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About CBNA CHAIN BRIDGE BANCORP INC

Chain Bridge Bancorp Inc is engaged in banking industry. It offers commercial and personal banking services, including deposits, treasury management, payments, loans, commercial lending, residential mortgage financing, consumer loans, trusts and estate administration, wealth management, and asset custody.

Share on Social Networks: